
Syngene International Ltd
NSE:SYNGENE


to continue SYNGENE research
to continue SYNGENE research
You've reached your weekly stock limit.
Sign UpSyngene International Ltd?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
610.7
947.8
|
Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Syngene International Ltd hold over its rivals?
What risks and challenges
does Syngene International Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Syngene International Ltd.
Provide an overview of the primary business activities
of Syngene International Ltd.
What unique competitive advantages
does Syngene International Ltd hold over its rivals?
What risks and challenges
does Syngene International Ltd face in the near future?
Has there been any significant insider trading activity
in Syngene International Ltd recently?
Summarize the latest earnings call
of Syngene International Ltd.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Syngene International Ltd.
Provide P/S
for Syngene International Ltd.
Provide P/E
for Syngene International Ltd.
Provide P/OCF
for Syngene International Ltd.
Provide P/FCFE
for Syngene International Ltd.
Provide P/B
for Syngene International Ltd.
Provide EV/S
for Syngene International Ltd.
Provide EV/GP
for Syngene International Ltd.
Provide EV/EBITDA
for Syngene International Ltd.
Provide EV/EBIT
for Syngene International Ltd.
Provide EV/OCF
for Syngene International Ltd.
Provide EV/FCFF
for Syngene International Ltd.
Provide EV/IC
for Syngene International Ltd.
Show me price targets
for Syngene International Ltd made by professional analysts.
What are the Revenue projections
for Syngene International Ltd?
How accurate were the past Revenue estimates
for Syngene International Ltd?
What are the Net Income projections
for Syngene International Ltd?
How accurate were the past Net Income estimates
for Syngene International Ltd?
What are the EPS projections
for Syngene International Ltd?
How accurate were the past EPS estimates
for Syngene International Ltd?
What are the EBIT projections
for Syngene International Ltd?
How accurate were the past EBIT estimates
for Syngene International Ltd?
Compare the revenue forecasts
for Syngene International Ltd with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Syngene International Ltd and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Syngene International Ltd against its competitors.
Analyze the profit margins
(gross, operating, and net) of Syngene International Ltd compared to its peers.
Compare the P/E ratios
of Syngene International Ltd against its peers.
Discuss the investment returns and shareholder value creation
comparing Syngene International Ltd with its peers.
Analyze the financial leverage
of Syngene International Ltd compared to its main competitors.
Show all profitability ratios
for Syngene International Ltd.
Provide ROE
for Syngene International Ltd.
Provide ROA
for Syngene International Ltd.
Provide ROIC
for Syngene International Ltd.
Provide ROCE
for Syngene International Ltd.
Provide Gross Margin
for Syngene International Ltd.
Provide Operating Margin
for Syngene International Ltd.
Provide Net Margin
for Syngene International Ltd.
Provide FCF Margin
for Syngene International Ltd.
Show all solvency ratios
for Syngene International Ltd.
Provide D/E Ratio
for Syngene International Ltd.
Provide D/A Ratio
for Syngene International Ltd.
Provide Interest Coverage Ratio
for Syngene International Ltd.
Provide Altman Z-Score Ratio
for Syngene International Ltd.
Provide Quick Ratio
for Syngene International Ltd.
Provide Current Ratio
for Syngene International Ltd.
Provide Cash Ratio
for Syngene International Ltd.
What is the historical Revenue growth
over the last 5 years for Syngene International Ltd?
What is the historical Net Income growth
over the last 5 years for Syngene International Ltd?
What is the current Free Cash Flow
of Syngene International Ltd?
Discuss the annual earnings per share (EPS)
trend over the past five years for Syngene International Ltd.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
IN |
![]() |
Syngene International Ltd
NSE:SYNGENE
|
258.7B INR | 23.8 | |
US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1.1T USD | 1 363.4 |
|
US |
![]() |
Thermo Fisher Scientific Inc
NYSE:TMO
|
162.1B USD | 17.3 |
|
US |
![]() |
Danaher Corp
NYSE:DHR
|
145.4B USD | 21.2 |
|
KR |
![]() |
Samsung Biologics Co Ltd
KRX:207940
|
74.1T KRW | 33.6 |
|
CH |
![]() |
Lonza Group AG
SIX:LONN
|
38.9B CHF | 22.4 |
|
US |
![]() |
Agilent Technologies Inc
NYSE:A
|
34.5B USD | 20 |
|
CN |
![]() |
WuXi AppTec Co Ltd
SSE:603259
|
206.2B CNY | 17.7 |
|
US |
![]() |
IQVIA Holdings Inc
NYSE:IQV
|
28.6B USD | 11.8 |
|
US |
![]() |
Mettler-Toledo International Inc
NYSE:MTD
|
25.1B USD | 22 |
|
FR |
![]() |
Sartorius Stedim Biotech SA
PAR:DIM
|
19.8B EUR | 30.9 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
IN |
![]() |
Syngene International Ltd
NSE:SYNGENE
|
Average EV/EBITDA:
144
23.8
|
14%
|
1.7 | |
US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1 363.4
|
7%
|
194.8 |
|
US |
![]() |
Thermo Fisher Scientific Inc
NYSE:TMO
|
17.3
|
6%
|
2.9 |
|
US |
![]() |
Danaher Corp
NYSE:DHR
|
21.2
|
7%
|
3 |
|
KR |
![]() |
Samsung Biologics Co Ltd
KRX:207940
|
33.6
|
17%
|
2 |
|
CH |
![]() |
Lonza Group AG
SIX:LONN
|
22.4
|
18%
|
1.2 |
|
US |
![]() |
Agilent Technologies Inc
NYSE:A
|
20
|
10%
|
2 |
|
CN |
![]() |
WuXi AppTec Co Ltd
SSE:603259
|
17.7
|
24%
|
0.7 |
|
US |
![]() |
IQVIA Holdings Inc
NYSE:IQV
|
11.8
|
9%
|
1.3 |
|
US |
![]() |
Mettler-Toledo International Inc
NYSE:MTD
|
22
|
4%
|
5.5 |
|
FR |
![]() |
Sartorius Stedim Biotech SA
PAR:DIM
|
30.9
|
20%
|
1.5 |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.